Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Vaxxa

0.56 SEK

-1.06 %

Less than 1K followers

VAXXA

Spotlight Stock Market

Software

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vaxxa

2019202020212022202320242025
Revenue1.50.64.745.754.977.075.2
growth-%-58.7 %644.5 %862.2 %20.2 %40.2 %-2.4 %
EBITDA-4.5-5.5-5.3-2.7-3.12.4-1.9
EBIT-4.7-7.4-7.9-46.1-4.30.3-4.2
Profit before taxes-4.7-7.4-12.5-50.8-5.10.4-4.1
Net income-4.7-7.4-12.8-51.1-5.10.4-4.1
EPS-18.64-5.37-5.28-6.930.000.01-0.10
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-294.2 %-866.2 %-111.4 %-6.0 %-5.6 %3.1 %-2.5 %
EBIT-%-305.0 %-1,166.3 %-166.7 %-100.9 %-7.9 %0.4 %-5.6 %
ROE-300.6 %-75.9 %-130.7 %-456.0 %-50.7 %2.0 %-20.5 %
ROI-144.1 %-66.1 %-111.8 %-239.8 %-28.7 %1.4 %-16.2 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.